The costs of caring: medical costs of Alzheimer's disease and the managed care environment.
This review summarizes the medical costs associated with Alzheimer's disease (AD) and related dementias, as well as the payers responsible for these medical costs in the US health care system. It is clear from this review that AD and related dementias are associated with substantial medical costs. The payers responsible for a majority of these costs are families of patients with AD and the US government through the Medicare and Medicaid programs. In an attempt to control expenditures, Medicare and Medicaid have turned to managed care principles and managed care organizations. The increase in "managed" dementia care gives rise to several potential problems for patients with AD, along with many opportunities for systematic improvement in the quality of dementia care. Evidence-based disease management programs provide the greatest opportunities for improving managed dementia care but will require the development of dementia-specific quality of care measures to evaluate and continually improve them.
Murman
D L
DL
Department of Neurology, Michigan State University, East Lansing, USA.
D000544:Alzheimer Disease / Q000191:economics* / Q000628:therapy; D003072:Cognition Disorders / Q000191:economics* / Q000628:therapy; D017281:Cost of Illness; D019468:Disease Management; D006801:Humans; D008329:Managed Care Programs / Q000191:economics* / Q000639:trends; D008484:Medicaid / Q000191:economics* / Q000639:trends; D006278:Medicare / Q000191:economics* / Q000639:trends